ONCO
Onconetix, Inc.
Key Financials
Gross Profit
$632913
↓ 40.0%
Operating Income
$-17856856
↑ 68.4%
Net Income
$-14032342
↑ 76.1%
EPS (Diluted)
$-16.56
↑ 22.8%
Revenue
$815371
↓ 67.7%
Total Assets
$24.9M
↓ 11.5%
Shareholders' Equity
$8.5M
↑ 252.5%
Total Liabilities
$9.2M
↓ 50.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/13/2026 | View on SEC |
| S-1 | 8/12/2026 | View on SEC |
| 425 | 8/6/2026 | View on SEC |
| 8-K | 7/29/2026 | View on SEC |
| SCHEDULE 13G | 7/27/2026 | View on SEC |
| 425 | 7/7/2026 | View on SEC |
| 425 | 6/24/2026 | View on SEC |
| 424B3 | 6/17/2026 | View on SEC |
| EFFECT | 6/16/2026 | View on SEC |
| S-1 | 6/9/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ONCO |
| Company Name | Onconetix, Inc. |
| CIK | 1782107 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 513-620-4101 |